Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 14026 - 14050 of 14528 in total
Candoxatril is the orally-active prodrug of candoxatrilat (UK-73967), a potent neutral endopeptidase (NEP) inhibitor.
Experimental
Experimental
BMS-564929 is an investigational therapeutic agent built to be a selective androgen receptor modulator (SARM). So far, it has been developed by Bristol-Myers Squibb for the symptomatic treatment of andropause.
Experimental
Experimental
Experimental
Investigational
MK-4965 is an HIV-1 reverse transcriptase inhibitor.
Experimental
Carmegliptin has been used in trials studying the treatment of Diabetes Mellitus Type 2.
Investigational
Displaying drugs 14026 - 14050 of 14528 in total